CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | 10 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Dec. 31, 2022 |
|
| Operating expenses: | ||||||||
| Warrant issuance expense | $ 500,307 | $ 500,307 | ||||||
| Exchange listing fees | $ 21,249 | $ 20,178 | $ 42,269 | 120,365 | 160,721 | |||
| Legal fees | 2,373,475 | 26,945 | 2,513,475 | 121,945 | 215,000 | |||
| General, administrative, and other expenses | 813,203 | 207,840 | 1,030,413 | 435,861 | $ 22,252 | 877,640 | ||
| Total operating expenses | 3,207,927 | 254,963 | 3,586,157 | 1,178,478 | 22,252 | 1,753,668 | ||
| Loss from operations | (3,207,927) | (254,963) | (3,586,157) | (1,178,478) | (22,252) | (1,753,668) | ||
| Other income (expenses): | ||||||||
| Change in fair value of warrant liability | (4,224,105) | 1,459,707 | (4,676,625) | 11,760,463 | 14,304,338 | |||
| Interest income on cash held in bank account | 4,259 | 15,090 | ||||||
| Interest income on treasury securities held in Trust Account | 1,173,738 | 392,079 | 3,891,253 | 457,476 | 3,939,359 | |||
| Interest income | 3,939,359 | |||||||
| Unrealized (loss) gain on treasury securities held in Trust Account | (91,323) | (38,227) | (107,187) | (38,227) | 57,498 | |||
| Other income | (3,137,431) | 1,813,559 | (877,469) | 12,179,712 | 18,301,195 | |||
| Income (loss) before provision for income taxes | (6,345,358) | 1,558,596 | (4,463,626) | 11,001,234 | (22,252) | 16,547,527 | ||
| Provision for income taxes | (236,909) | (108,421) | (799,505) | (108,421) | (783,546) | |||
| Net (loss) income | $ (6,582,267) | $ 1,319,136 | $ 1,450,175 | $ 9,442,637 | $ (5,263,131) | $ 10,892,813 | $ (22,252) | $ 15,763,981 |
| Class A common stock | ||||||||
| Other income (expenses): | ||||||||
| Basic weighted average shares outstanding | 8,648,990 | 24,150,000 | 16,356,675 | 21,081,215 | 22,604,795 | |||
| Diluted weighted average shares outstanding | 8,648,990 | 24,150,000 | 16,356,675 | 21,081,215 | 22,604,795 | |||
| Basic net (loss) income per share | $ 0.53 | |||||||
| Diluted net (loss) income per share | $ 0.53 | |||||||
| Redeemable Class A common stock | ||||||||
| Other income (expenses): | ||||||||
| Net (loss) income | $ (3,581,854) | $ 1,115,519 | $ (3,647,509) | $ 8,106,757 | $ 11,937,823 | |||
| Basic weighted average shares outstanding | 8,684,990 | 24,150,000 | 16,356,675 | 21,081,215 | 22,604,795 | |||
| Diluted weighted average shares outstanding | 8,684,990 | 24,150,000 | 16,356,675 | 21,081,215 | 22,604,795 | |||
| Basic net (loss) income per share | $ (0.41) | $ 0.05 | $ (0.22) | $ 0.38 | $ 0.53 | |||
| Diluted net (loss) income per share | $ (0.41) | $ 0.05 | $ (0.22) | $ 0.38 | $ 0.53 | |||
| Non-redeemable Class A and Class B common stock | ||||||||
| Other income (expenses): | ||||||||
| Net (loss) income | $ (3,000,413) | $ 334,656 | $ (1,615,622) | $ 2,786,056 | ||||
| Basic weighted average shares outstanding | 7,245,000 | 7,245,000 | 7,245,000 | 7,245,000 | ||||
| Diluted weighted average shares outstanding | 7,245,000 | 7,245,000 | 7,245,000 | 7,245,000 | ||||
| Basic net (loss) income per share | $ (0.41) | $ 0.05 | $ (0.22) | $ 0.38 | ||||
| Diluted net (loss) income per share | $ (0.41) | $ 0.05 | $ (0.22) | $ 0.38 | ||||
| X | ||||||||||
- Definition The amount represents change in fair value of Warrant Liability. No definition available.
|
| X | ||||||||||
- Definition The amount of exchange listing fees incurred during the period. No definition available.
|
| X | ||||||||||
- Definition The amount of aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No definition available.
|
| X | ||||||||||
- Definition The amount of warrant issuance expense incurred during the period. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|